Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on …

Artículos que citan Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on …

Título / Autor	Año
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug H Wu, E Esteve, V Tremaroli, MT Khan, R Caesar, L Mannerås-Holm, ... Nature medicine 23 (7), 850	2017
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota J Wang, LB Thingholm, J Skiecevičienė, P Rausch, M Kummen, JR Hov, ... Nature genetics 48 (11), 1396	2016
Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid–producing microbiota in the gut J De La Cuesta-Zuluaga, NT Mueller, V Corrales-Agudelo, ... Diabetes care 40 (1), 54-62	2017
The role of the microbiome in human health and disease: an introduction for clinicians VB Young Bmj 356, j831	2017
The human microbiota in health and disease B Wang, M Yao, L Lv, Z Ling, L Li Engineering 3 (1), 71-82	2017
Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity AC Nicolucci, MP Hume, I Martínez, S Mayengbam, J Walter, RA Reimer Gastroenterology 153 (3), 711-722	2017
Anticancer effects of the microbiome and its products L Zitvogel, R Daillere, MP Roberti, B Routy, G Kroemer Nature Reviews Microbiology 15 (8), 465	2017
Lipotoxicity and the gut-liver axis in NASH pathogenesis F Marra, G Svegliati-Baroni Journal of hepatology 68 (2), 280-295	2018
Role of gut microbiota in atherosclerosis AL Jonsson, F Bäckhed Nature Reviews Cardiology 14 (2), 79	2017
An intestinal microbiota–farnesoid X receptor axis modulates metabolic disease FJ Gonzalez, C Jiang, AD Patterson Gastroenterology 151 (5), 845-859	2016
Targeting the gut-liver axis in liver disease R Wiest, A Albillos, M Trauner, JS Bajaj, R Jalan Journal of hepatology 67 (5), 1084-1103	2017
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy R Tang, Y Wei, Y Li, W Chen, H Chen, Q Wang, F Yang, Q Miao, X Xiao, ... Gut 67 (3), 534-541	2018
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment Y Gu, X Wang, J Li, Y Zhang, H Zhong, R Liu, D Zhang, Q Feng, X Xie, ... Nature communications 8 (1), 1785	2017
Microbiota-gut-brain axis: modulator of host metabolism and appetite M van de Wouw, H Schellekens, TG Dinan, JF Cryan The Journal of nutrition 147 (5), 727-745	2017
The gut–liver axis and the intersection with the microbiome A Tripathi, J Debelius, DA Brenner, M Karin, R Loomba, B Schnabl, ... Nature reviews Gastroenterology & hepatology 15 (7), 397	2018
Microbiome-modulated metabolites at the interface of host immunity E Blacher, M Levy, E Tatirovsky, E Elinav The Journal of Immunology 198 (2), 572-580	2017
New therapeutic concepts in bile acid transport and signaling for management of cholestasis M Trauner, CD Fuchs, E Halilbasic, G Paumgartner Hepatology 65 (4), 1393-1404	2017
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome S Ussar, S Fujisaka, CR Kahn Molecular metabolism 5 (9), 795-803	2016
Linking the microbiota, chronic disease, and the immune system TW Hand, I Vujkovic-Cvijin, VK Ridaura, Y Belkaid Trends in Endocrinology & Metabolism 27 (12), 831-843	2016
Role of bile acids in metabolic control A Molinaro, A Wahlström, HU Marschall Trends in Endocrinology & Metabolism 29 (1), 31-41	2018

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.